CNBC's "Fast Money"

Elon Musk's controversial $56 billion pay package at Tesla, relocation discussions, media stock trends. Trump's economic policies, tax reforms, and market updates. Adobe's strong earnings, Paramount-Warner Bros Discovery changes. Musk's future plans for Tesla, media stocks under pressure, liver disease treatment competition.

Federal Reserve keeps rates unchanged, focus on inflation progress. Impact on financial stocks discussed. Broadcom's stellar performance, stock split announced. Market performance, investment opportunities in AI highlighted. Bank trades analyzed, potential impact of Fed decision on financials.

The CEO of Structure Therapeutics discusses the weight loss market and their promising GLP-1 pill. Apple's stock hits record highs post-AI announcement. The podcast also covers market momentum, tech stocks, labor market impact, and the competitiveness of Structure Therapeutics' weight loss drug.

Apple introduces Apple Intelligence at WWDC with AI advancements, including ChatGPT. European elections leaning right impact markets. Nvidia and AMD stock performance post-split analyzed. Eli Lilly gains FDA support for Alzheimer's drug. European political landscape and market performance discussed.

Rates surge after strong jobs report, impacting Fed rate cut likelihood. Gamestop dips with stock sale plans. Roaring Kitty's livestream fails to boost shares. Apple's AI strategies and Gamestop woes discussed.

Jim Lebenthal, a veteran investor with a science-minded approach to fundamental analysis and value investing, discusses his unique background and how he uses different fundamental analytical tools to find price-to-earnings growth ratios of stocks like Amazon and Nvidia. He also talks about incorporating tools from technical analysis and answers stock-specific questions from Pro subscribers, emphasizing the importance of going back to the fundamentals for better investment decisions.

Commodities prices rise while rates fall, signaling market trends. FDA flags concerns over Eli Lilly's Alzheimer's drug impact. Discussing investments in changing market landscape, Amazon vs. Walmart growth, and antitrust investigations into AI industry players.

The podcast delves into Nvidia's stock performance surpassing Apple, semiconductor market dynamics, and Lulu Lemon's strong earnings. It explores upcoming rate decisions, tax policy concerns, and Dollar Tree's potential sale. Additionally, they discuss Roach Holdings' weight loss drug and Boeing's successful Starliner launch, along with analyzing stock performance and final trade recommendations.

Traders discuss a key market chart predicting stock movements. Telehealth company tracks weight loss drug shortage. Market analysis of Consumer Discretionary ETF performance, banking sector, and HP Enterprise earnings. Retail challenges, Indian market reversals, and pharmaceutical companies' strategies are explored.

Podcast discusses major moves in oil, homebuilders, and chip stocks. Examines election impact on India and Mexico markets. Explores SEC review, market manipulation, social media influence on trading. Considers regulating social media algorithms for teens. Delves into challenges in Mexico's industrial sector. Ends with market opportunities and trade recommendations.